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Abstract Glucose-induced insulin secretion is pulsatile. We in-
vestigated how the triggering pathway (rise in L-cell [Ca2+]i)
and amplifying pathway (greater Ca2+ e⁄cacy on exocytosis)
in£uence this pulsatility. Repetitive [Ca2+]i pulses were imposed
by high K++ diazoxide in single mouse islets. Insulin secretion
(measured simultaneously) tightly followed [Ca2+]i changes.
Lengthening [Ca2+]i pulses increased the duration but not the
amplitude of insulin pulses. Increasing glucose (5^20 mmol/l)
augmented the amplitude of insulin pulses without changing
that of [Ca2+]i pulses. Larger [Ca2
+]i pulses augmented the
amplitude of insulin pulses at high, but not low glucose. In
conclusion, the ampli¢cation pathway ensures amplitude modu-
lation of insulin pulses whose time modulation is achieved by the
triggering pathway.
0 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Glucose precisely regulates insulin secretion by producing
triggering and amplifying signals in L-cells [1,2]. A rise in
cytoplasmic free Ca2þ concentration ([Ca2þ]i), resulting from
membrane depolarization and Ca2þ in£ux is the signal that
triggers exocytosis of insulin granules [3^8]. The nature of the
amplifying signal is still disputed [7^11] but there is strong
evidence that this pathway serves to augment the e⁄ciency
of Ca2þ on exocytosis [1].
Insulin secretion is pulsatile [12^14]. In normal mouse and
human islets, [Ca2þ]i regularly oscillates during glucose stim-
ulation [15^22]. These oscillations of [Ca2þ]i, driven by waves
of membrane potential changes, are accompanied by synchro-
nous pulses of insulin secretion [16^18]. Moreover, imposed
[Ca2þ]i pulses, induced by repetitive depolarizations with high
extracellular Kþ, also trigger synchronous pulses of insulin
secretion, whereas sustained elevation of [Ca2þ]i causes sus-
tained insulin secretion [23^25]. These observations suggest
that [Ca2þ]i is the instantaneous regulator of the rate of in-
sulin secretion. However, insulin secretion also oscillates in rat
islets [26,27], although L-cells are continuously depolarized
and [Ca2þ]i steadily elevated by glucose [22]. Dissociations
between [Ca2þ]i and insulin secretion oscillations have also
been reported in leptin-de¢cient ob/ob mouse islets [28]. It
was thus proposed that, in some species or under certain
conditions, amplifying signals cyclically produced by glucose
can override the continuous triggering action of Ca2þ [29].
The amplifying pathway of glucose-induced insulin secre-
tion has been discovered and subsequently characterized by
using experimental paradigms holding L-cell [Ca2þ]i stably
elevated [1]. It is not known whether the amplifying mecha-
nism remains e¡ective when [Ca2þ]i £uctuates in L-cells and
could explain the paradox that insulin secretion pulses mainly
increase in amplitude when the glucose concentration is raised
whereas the concomitant [Ca2þ]i oscillations increase in dura-
tion, not in amplitude [15,18,22,30]. This was the question
addressed in the present study by using single mouse islets
in which [Ca2þ]i and metabolism were experimentally con-
trolled. Thus, diazoxide was used to avoid that changes in
glucose in£uence [Ca2þ]i by a¡ecting the membrane potential,
and size-controlled, regular [Ca2þ]i pulses were imposed by
repetitive increases and decreases of the extracellular Kþ con-
centration. Insulin secretion was measured simultaneously
from the same islets [23,24].m:/Typ/
2. Materials and methods
2.1. Preparation and solutions
Islets were aseptically isolated by collagenase digestion of the pan-
creas of female NMRI mice, selected by hand-picking and cultured
for 1 day in RPMI 1640 medium containing 10 mmol/l glucose [23].
The control medium used for islet isolation contained (mmol/l) 120
NaCl, 4.8 KCl, 2.5 CaCl2, 1.2 MgCl2, 24 NaHCO3, 10 glucose, and
1 mg/ml bovine serum albumin. It was gassed with O2/CO2 (94/6) to
maintain a pH of 7.4. The same medium with 0.1 mmol/l diazoxide
was used for all experiments. When the concentration of KCl was
increased to 30 mmol/l, that of NaCl was decreased, and when the
concentration of CaCl2 was decreased, that of MgCl2 was increased
accordingly to maintain iso-osmolarity.
2.2. Combined measurements of [Ca2þ]i and insulin secretion
Cultured islets were loaded with fura-PE3 during 2 h of incubation
at 37‡C in control medium containing 2 Wmol/l fura-PE3 acetoxy-
methyl ester and 5 mmol/l glucose. After loading, one single islet
was transferred into a perifusion chamber (110 Wl) with a bottom
made of a glass coverslip and mounted on the stage of an inverted
microscope equipped for [Ca2þ]i measurement [16]. The islet was held
in place with a micropipette and perifused at a £ow rate of 1.8 ml/
min. To induce repetitive [Ca2þ]i pulses in L-cells, the concentration of
Kþ was alternated between 4.8 and 30 mmol/l. The medium (37‡C)
was collected, in fractions of 30 s, just downstream of the islet. Insulin
was measured, in duplicate 400 Wl aliquots of the e¥uent fractions,
using rat insulin as a standard [23]. At the end of the experiments the
islet was recovered and its content in insulin was measured (88.0H 4.7
ng, n=45). Insulin secretion could thus be expressed as a percentage
of insulin content.
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2.3. Presentation of results
The results are presented as mean traces ( HS.E.M.) for four to six
experiments with islets obtained from di¡erent preparations. The ef-
fects of the di¡erent types of stimulations were quanti¢ed by comput-
ing the di¡erence (v) between average [Ca2þ]i or insulin secretion rate
and baseline during the periods of interest (see legends to ¢gures for
details). The statistical signi¢cance of di¡erences between means was
assessed by Student’s t-test (paired or unpaired as appropriate) or by
analysis of variance followed by a Newman^Keuls test when more
than two groups were compared. Di¡erences were considered signi¢-
cant at P6 0.05.
3. Results
3.1. Ampli¢cation of insulin secretion by glucose during
intermittent [Ca2þ ]i elevation
Controlled [Ca2þ]i pulses in L-cells were imposed by repet-
itive depolarizations induced by alternating between 4.8 and
30 mmol/l Kþ every 2 min (Fig. 1A,B). The concentration of
extracellular CaCl2 was kept constant at 1 or 2.5 mmol/l
throughout, but that of glucose was increased from 5 to 20
mmol/l in the middle of the experiment. This increase pro-
duced a consistent, albeit small attenuation of the [Ca2þ]i
pulse that was concomitantly imposed. On the average traces,
this can be seen as a shoulder in the ascending phase of the
[Ca2þ]i pulse occurring between 18 and 20 min (Fig. 1A,B).
Each [Ca2þ]i pulse triggered a pulse of insulin secretion.
The increase in glucose concentration augmented the secretory
responses. The e¡ect was most marked on the ¢rst pulse in
1 mmol/l CaCl2 (Fig. 1A), but was more sustained in 2.5
mmol/l CaCl2 (Fig. 1B). The quanti¢cation of the changes
in [Ca2þ]i and insulin is shown in the lower panels of Fig. 1.
Mean [Ca2þ]i was marginally higher during the last than the
¢rst four pulses, but this small di¡erence achieved statistical
signi¢cance only in islets perifused in low CaCl2 (Fig. 1C). A
similar small increase in Ca2þ occurs when Kþ pulses are
applied at constant glucose throughout or when Kþ is steadily
elevated, and appears to re£ect a slow drift of apparent
[Ca2þ]i with time [23^25]. Contrasting with the quasi-stability
of [Ca2þ]i pulses, the amplitude of the insulin pulses was in-
creased two- to three-fold by 20 mmol/l glucose, the relative
change being larger during perifusion with 2.5 than 1 mmol/l
CaCl2.
3.2. Interactions between [Ca2þ ]i and glucose concentration in
the ampli¢cation of pulsatile insulin secretion
In these experiments, the concentration of glucose was kept
Fig. 1. Amplitude modulation of insulin secretion triggered by [Ca2þ]i pulses in L-cells. A,B: [Ca2þ]i and insulin secretion were measured in the
same single islets. The Kþ concentration was alternated between 4.8 and 30 mmol/l every 2 min as indicated, whereas that of glucose (G) was
raised from 5 to 20 mmol/l at 18 min. Two depolarizations with Kþ were applied before [Ca2þ]i and insulin measurements were started, hence
the decreasing values between 0 and 2 min. C,D: Quanti¢cation of the changes (v) in [Ca2þ]i and insulin secretion. v [Ca2þ]i is the di¡erence
between mean [Ca2þ]i from 2 to 18 min or from 18 to 34 min and baseline [Ca2þ]i determined as mean nadir between oscillations in G5. v in-
sulin was calculated in a similar way. *P6 0.05 or less versus G5. Values are meansHS.E.M. for six islets.
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constant at 5 or 20 mmol/l, but the amplitude of the forced
[Ca2þ]i pulses was increased by raising extracellular CaCl2
from 1 to 1.5 and 2.5 mmol/l during repetitive depolarizations
with 30 mmol/l Kþ (Fig. 2). The impact on insulin secretion
was dependent on the ambient glucose concentration. The
amplitude of insulin pulses increased with that of [Ca2þ]i
pulses in 20 mmol/l glucose (Fig. 2B) but did not signi¢cantly
change in 5 mmol/l glucose (Fig. 2A). Similar results were
obtained in two experiments performed in reverse order, i.e.
by decreasing extracellular CaCl2 from 2.5 to 1.5 and 1 mmol/l
during the pulses with high Kþ (not illustrated). The quanti-
¢cation of the combined sets of results is presented in Fig.
3A,B, and the relationships between [Ca2þ]i and insulin secre-
tion are shown in Fig. 3C. For any increase in [Ca2þ]i, insulin
secretion was more strongly stimulated in 20 than 5 mmol/l
glucose. Whereas the secretory response increased with [Ca2þ]i
in high glucose, no similar dependence was found in low glu-
cose. The di¡erence between the secretory responses at low
and high glucose increased with the amplitude of the [Ca2þ]i
pulse (Fig. 3C).
3.3. Relative impact of [Ca2þ ]i and glucose concentration
changes on the pulses of insulin secretion
The preceding experiments have shown that glucose aug-
ments the insulin response triggered by imposed [Ca2þ]i pulses
with little or no e¡ect on the amplitude of the latter. Under
physiological conditions, when the membrane potential of L-
cells is not experimentally controlled as here, an increase in
glucose from an already stimulatory to an even higher con-
centration increases the duration of [Ca2þ]i oscillations and
barely a¡ects their amplitude [15,18,22,30]. These changes
were thus mimicked by changing the duration of the imposed
periods of depolarization (Fig. 4). When the glucose concen-
tration was kept at 5 mmol/l, doubling the duration of the
forced [Ca2þ]i elevations lengthened the periods of insulin
secretion but did not in£uence their amplitude (Fig. 4A). In
contrast, when the glucose concentration was increased simul-
taneously with the lengthening of the forced [Ca2þ]i oscilla-
tions, the amplitude of the insulin secretion pulses was clearly
increased (Fig. 4B).
Fig. 2. In£uence of glucose on insulin secretion triggered by [Ca2þ]i
pulses of increasing amplitude. [Ca2þ]i and insulin secretion were
measured in the same single islets. The Kþ concentration was alter-
nated between 4.8 and 30 mmol/l every 2 min as indicated. The glu-
cose concentration was 5 or 20 mmol/l throughout (G5 or G20),
and that of extracellular CaCl2 was increased stepwise as indicated.
Values are meansHS.E.M. for four islets.
Fig. 3. Quanti¢cation of [Ca2þ]i and insulin secretion changes in the
experiments of Fig. 2 and in two similar experiments in which extra-
cellular CaCl2 was changed in reverse order. v [Ca2þ]i and v insulin
were calculated as in Fig. 1. A,B: *P6 0.05 or less between 1.5 and
1 mmol/l CaCl2 and #P6 0.01 between 2.5 and 1.5 mmol/l CaCl2.
C: Relationship between v insulin secretion and v [Ca2þ]i in 5 or
20 mmol/l glucose (G5 or G20) and 1, 1.5 or 2.5 mmol/l CaCl2 as
indicated. *P6 0.05, ***P6 0.001. Values are meansHS.E.M. for
six islets.
FEBS 26657 9-10-02
M.A. Ravier, J.-C. Henquin/FEBS Letters 530 (2002) 215^219 217
4. Discussion
The present study shows that the amplifying pathway of
glucose control of insulin secretion is operative when [Ca2þ]i
is forced to change repetitively, in a way resembling the slow
[Ca2þ]i oscillations occurring in glucose-stimulated mouse is-
lets. Thus, glucose markedly increased the amplitude of the
insulin secretion pulses although the size of the triggering
[Ca2þ]i pulses barely changed. Previous experiments have es-
tablished that an elevation of [Ca2þ]i in L-cells is necessary for
the amplifying action of glucose to manifest itself [1]. The
novel information is that this [Ca2þ]i elevation does not
have to be continuous, as was the case in all previously
used paradigms. The fact that the amplifying pathway in-
creases insulin secretion when [Ca2þ]i oscillates validates pre-
vious extrapolations on the role of this pathway under phys-
iological conditions, such as the second phase of glucose
stimulation in mouse and human islets. It is noteworthy
that the selected rhythm of imposed [Ca2þ]i oscillations was
similar to the frequency of the major spontaneous slow oscil-
lations of [Ca2þ]i in glucose-stimulated islets [6,17] and of the
oscillations of insulin secretion in vitro and in vivo [6,14].
Using controlled stepwise, sustained elevations of [Ca2þ]i in
mouse islets, we previously showed that the amplifying action
of glucose on insulin secretion increases with [Ca2þ]i [23]. A
similar phenomenon was observed here for imposed [Ca2þ]i
pulses. Thus, increasing the amplitude of [Ca2þ]i pulses at low
glucose or increasing the glucose concentration at modestly
elevated [Ca2þ]i had little impact on insulin secretion as com-
pared with the marked ampli¢cation of insulin secretion that
accompanied similar changes at higher glucose or [Ca2þ]i.
In mouse islets studied in vitro, when ambient glucose is
increased from a moderately stimulatory to a strongly stim-
ulatory concentration, the phases of depolarization increase in
duration, and so do the corresponding oscillations of [Ca2þ]i
[6,22]. Importantly, although the amplitude of these [Ca2þ]i
oscillations does not change, that of the accompanying insulin
pulses increases [30]. In single perifused mouse islets [26], in
batches of perifused rat islets [27] and in normal human sub-
jects [14], a rise in the glucose concentration also essentially
increases the amplitude of the slower pulses of insulin secre-
tion. There is thus an apparent discrepancy between a consis-
tent increase of pulsatile secretion and no change in the am-
plitude of [Ca2þ]i oscillations in islets. Two explanations have
tentatively been proposed. First the increase in glucose might
recruit more and more L-cells into an active state [26]. How-
ever, the homogeneity of [Ca2þ]i changes in di¡erent regions
of the islets [6,19,21,30] and the evidence that recruitment to
produce a Ca2þ response is virtually complete at 10 mmol/l
glucose [31] do not support the hypothesis. At least, if recruit-
ment into a secretory state is involved, the implicated mech-
anism is not only the [Ca2þ]i rise [31]. Second, the lengthening
of the period of [Ca2þ]i elevation has been suggested to cause
not only a longer, but also a larger phase of insulin secretion
[18]. The present study refutes this interpretation. Mere
lengthening of the [Ca2þ]i pulse did not in£uence the ampli-
tude of the insulin pulses, whereas the rise in glucose concen-
tration increased it. The amplifying pathway thus seems to
underlie this increase in amplitude.
We still do not know why the L-cell response to glucose is
oscillatory. One widely held view is that pulsatile insulin se-
cretion optimizes the peripheral action of the hormone [12^
14]. Alternatively, oscillations of di¡erent signals, including
[Ca2þ]i, may be important for L-cell functions other than se-
cretion itself [6,32]. The present study suggests a possible func-
tional advantage of [Ca2þ]i oscillations. An intermittent larger
rise of [Ca2þ]i as that occurring at the peak of each [Ca2þ]i
oscillation may reach a concentration zone where the amplify-
ing action of glucose is e¡ective, whereas a lesser, sustained
[Ca2þ]i rise would not. Anyhow, the coexistence of a time-
dependent modulation via the triggering pathway and an am-
plitude-dependent modulation via the amplifying pathway en-
sures tight regulation of insulin secretion.
Acknowledgements: This work was supported by grants from the
Fonds National de la Recherche Scienti¢que, the General Direction
of Scienti¢c Research of the French Community of Belgium, and
the Federal O⁄ce for Scienti¢c, Technical, and Cultural A¡airs
from Belgium. We thank F. Knockaert for technical assistance and
V. Lebec for editorial help.
Fig. 4. Time and amplitude modulation of insulin secretion trig-
gered by [Ca2þ]i pulses in L-cells. [Ca2þ]i and insulin secretion were
measured in the same single islets. The Kþ concentration was in-
creased from 4.8 to 30 mmol/l for 2 min every 4 min, or for 4 min
every 6 min as indicated. The concentration of glucose (G) was ei-
ther kept at 5 mmol/l throughout (A) or increased from 5 to 20
mmol/l together with the lengthening of the Kþ pulses (B). Values
are meansHS.E.M. for six islets.
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